Carregant...

Azacitidine in the management of patients with myelodysplastic syndromes

Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoeitic disorders characterized by ineffective hematopoiesis and potential transformation to acute myeloid leukemia (AML). For decades, the mainstay of treatment for MDS was supportive care, including transfusion of blood prod...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Khan, Cyrus, Pathe, Neeta, Fazal, Salman, Lister, John, Rossetti, James M.
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3627328/
https://ncbi.nlm.nih.gov/pubmed/23606938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620712464882
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!